This page shows the latest escitalopram news and features for those working in and with pharma, biotech and healthcare.
mature products like epilepsy therapies Onfi (clobazam) and Sabril (vigabatrin) and antidepressant Cipralex (escitalopram).
Sales of antidepressant Cipralex (escitalopram) and anti-epileptic Sabril (vigabatrin) also suffered double-digit declines, more than offsetting growth of Lundbeck’s four strategic brands.
protection for Abilify and former blockbuster antidepressant Lexapro/Celexa (escitalopram).
Since its former blockbuster Cipralex (escitalopram) started to succumb to generic competition, Lundbeck has looked to two newer antidepressants - Brintellix/Trintellix (vortioxetine) and Rexulti (brexpiprazole) - to step in and fill the
sales from drugs such as depression treatment Cipralex (escitalopram).
Brintellix has been on the market in the US since 2013 and has been positioned as a successor to its older antidepressant Cipralex (escitalopram), which was selling around $2bn a year
More from news
Approximately 2 fully matching, plus 40 partially matching documents found.
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...